Sequenom Reports Third Quarter and First Nine Months 2010 Financial Results: Loss Per Share of $0.30

Sequenom, Inc. SQNM today reported its financial results for the third quarter and nine-months ended September 30, 2010. Third Quarter Results * Total revenue for the third quarter of 2010 grew 27% to $11.7 million, compared with $9.2 million for the third quarter of 2009. The increase in revenue compared to the same period last year was primarily due to higher system, services and consumables sales and the addition of revenues from sales of laboratory developed tests. * Net loss for the third quarter of 2010 was $22.7 million, or $0.30 per share, compared with $14.9 million, or $0.24 per share, for the third quarter of 2009. Net loss includes a $7.0 million non-cash charge taken by the company related to the revaluation of its litigation settlement for the approximately 6.4 million shares that will be issued to the class members in the consolidated federal securities class actions to a fair value of $7.01 per share as of September 30, 2010.